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Abstract
Background: Vaccines, that target human papillomavirus (HPV) high risk genotypes 16 and 18,
have recently been developed. This study was aimed at determining genotypes commonly found in
high-risk and multiple-HPV infections in Jamaican women. Two hundred and fifty three (253)
women were enrolled in the study. Of these, 120 pregnant women, aged 15–44 years, were
recruited from the Ante Natal Clinic at the University Hospital of the West Indies and 116 non-
pregnant, aged 19–83, from a family practice in Western Jamaica. Cervical cell samples were
collected from the women and HPV DNA was detected using Polymerase Chain Reaction and
Reverse Line Hybridization. HPV genotypes were assessed in 236 women. Data were collected
from January 2003 to October 2006.
Results: HPV DNA was detected in 87.7% (207/236) and of these 80.2% were positive for high-
risk types. The most common high-risk HPV types were: HPV 45 (21.7%), HPV 58 (18.8%), HPV
16 (18.4%), HPV 35 (15.0%), HPV 18 (14.5%), HPV 52 (12.0%) and HPV 51(11.1%). Other high-risk
types were present in frequencies of 1.4% – 7.2%.
Multivariate regression analyses showed that bacterial vaginosis predicted the presence of multiple
infections (OR 3.51; CI, 1.26–9.82) and that alcohol use (OR 0.31; CI, 0.15–0.85) and age at first
sexual encounter (12–15 years: OR 3.56; CI, 1.41–9.12; 16–19 years, OR 3.53, CI, 1.22–10.23)
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were significantly associated with high risk infections. Cervical cytology was normal in the majority
of women despite the presence of high-risk and multiple infections.
Conclusion: HPV genotype distribution in this group of Jamaican women differs from the patterns
found in Europe, North America and some parts of Asia. It may be necessary therefore to consider
development of other vaccines which target genotypes found in our and similar populations. HPV
genotyping as well as Pap smears should be considered.
Background
Infection with oncogenic human papillomavirus (HPV)
types is the primary cause of cervical cancer, the second
most common cancer among women worldwide [1]. In
developing countries, cervical cancer is second to breast
cancer as the cause of cancer deaths in women of repro-
ductive age [2] and is still a significant public health prob-
lem among women in the Caribbean [3]. To date, over
200 HPV types of which 40 types infect the genital tract,
have been identified worldwide [4]. The most recent data
show that in Jamaica, the age-specific incidence is 19/
100,000 [5]. HPV genotypes 16, 18 and 45 were identified
in Colposcopy clinic patients [6]. The development of a
prophylactic vaccine that targets HPV 6, 11, 16 and 18 has
increased interest in the ethnic and geographical distribu-
tions of HPV genotypes. This study focuses on the pres-
ence of high-risk and multiple HPV infections in a
population of cancer-free Jamaican women and seeks to
determine whether HPV infection is associated with life-
style and sexual practices.
Materials and methods
Study population
Two hundred and thirty six women were enrolled in the
study: 120 pregnant women aged 15 – 44 years (median
age 27.5 years) at their first antenatal clinic visit to the
University Hospital of the West Indies (UHWI) in King-
ston, Jamaica and 116 non-pregnant women (median age
35 years) attending a family practice in Western Jamaica.
Selection of the participants was consecutive. Participants
were asked to complete a questionnaire that assessed
information on socio-demographic factors, sexual prac-
tices and history of sexually transmitted infections (STI).
Ethical approval was obtained from the University of the
West Indies (UWI)/UHWI Ethical Committee. Informed
consent was obtained from all participants. Participants
were recruited January 2003 – October 2006.
Sample collection
At enrollment, a routine gynecological examination was
conducted and cervical specimens were collected first for
Papanicolaou (Pap) smear and for HPV testing. The cervi-
cal cells for HPV testing were taken from the endocervix
with one to two cytobrushes. The brushes were then agi-
tated in a 15 ml tube containing 1 ml of specimen trans-
port medium (Roche Diagnostics, Germany) for several
seconds to release the cells. The cervical cells were stored
at -20°C until further processing. Cytology results were
obtained from Pap smears. Cytological abnormalities
were classified according to the Bethesda classification
system as within normal limits or reactive cellular changes
(normal); atypical squamous cells of undetermined sig-
nificance (ASCUS); cervical intraepithelial neoplasia I
(CINI); cervical intraepithelial neoplasia II (CINII); cervi-
cal intraepithelial neoplasia III (CINIII) and carcinoma.
Detection and genotyping of HPV
Briefly, 250 μl aliquot of the cervical cell sample collected
in the specimen transport medium was lysed in the pres-
ence of proteinase K. Isolation and purification of the
released nucleic acid were carried out using columns and
elution reagents and the presence of HPV DNA was
detected using PCR-based methods: AMPLICOR [7] and
the Roche Linear Array HPV genotyping test protocol [8].
This method uses biotinylated primers to define the spe-
cific L1 region of the HPV genome and is able to detect 37
HPV genotypes (6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42,
45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68,
69, 70, 71, 72, 73, 81, 82, 83, 84, IS39 and CP6108). The
HPV genotype strips contain probe lines specific to the
detection of the 37 HPV types and 2 concentrations of the
β-globin control probe. For detection, the PCR products
were denatured and then 75 μl of the denatured amplicon
was added to the probe strip in a hybridization buffer.
After the final wash, the strips were incubated in a buffer
containing streptavidin-horseradish peroxidase conjugate
to facilitate detection of the different HPV types. The
buffer was then removed by vacuum aspiration, and the
strips rinsed in a citrate solution. Colour development
was activated by incubation in a mixture of hydrogen per-
oxide in citrate solution and tetramethylbenzidine in
dimethylformamide for 5 minutes, on a rotating platform
at 60 rpm. Strip interpretation was performed using a
labeled reference guide, with lines indicating the position
of each probe relative to a HPV type reference mark. We
considered HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51,
52, 56, 58, 59, and 68 as primary carcinogenic (high-risk)
types and all others as non-oncogenic (low-risk) types [9].
Ten subjects who were HPV-positive (using the AMPLI-
COR method) were not assigned to a genotype.Infectious Agents and Cancer 2009, 4(Suppl 1):S11 http://www.infectagentscancer.com/content/4/S1/S11
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Statistical analysis
Chi-square statistics were used in the cross-classification
of the presence of HPV infection and lifestyle/sexual prac-
tices characteristics. Multiple logistic regression analyses
were used to examine the association of sexual and life-
style behaviours with HPV infections. Statistical analyses
were performed by the Statistical Package for Social Sci-
ences (SPSS version 12).
Results
Table 1 displays the distribution of HPV infections accord-
ing to demographic, lifestyle and sexual practice variables.
Substantially more pregnant than non-pregnant women
had HR-HPV infections and few women who reported
that they had never been pregnant had HR-HPV infec-
tions. Almost all the HPV-positive women were diagnosed
with normal cytology. Alcohol consumption was lowest
in high-risk HPV-positive women. HPV prevalence did
Table 1: Comparison of demographic, lifestyle and sexual practice variables in HPV-negative and HPV-positive women.
HPV-negative
n = 29
Low risk
HPV-positive
n = 39
High-risk HPV-positive
n = 158
Pregnancy:*
Pregnant 44.8 (13) 51.3 (20) 65.8 (104)
Non-pregnant 55.2 (16) 48.7 (19) 3402 (54)
Gravidity:
0 13.8 (4) 10.3 (4) 5.7 (9)
1–2 48.3 (14) 43.6 (17) 50.0 (79)
3 or more 37.9 (11) 46.3 (18) 44.3 (70)
Parity:
0 34.5 (10) 35.9 (14) 34.0 (52)
1–2 34.5 (10) 46.2 (18) 51.0 (78)
3 or more 31.0 (9) 17.9 (7) 15.0 (23)
Age at first sexual intercourse:†
<16 years 36.0 (9) 16.7 (6) 25.2 (35)
16 – 19 18.0 (12) 61.1 (22) 66.9 993)
20 years older: 16.0 (4) 22.2 (8) 7.9 (11)
Cytology diagnosis:
Normal 91.3 (21) 96.9 (31) 93.6 (131)
Dysplasia 8.7 (2) 3.1 (1) 6.4 (9)
Bacterial vaginosis 13.0 (3) 3.1 (1) 14.3 (20)
Reported sexually transmitted infections
Yes 86.2 (25) 76.9 (30) 79.2 (122)
No 13.8 (4) 23.1 (90 20.8 (32)
Age groups:
<25 years 27.6 (8) 28.6 (10) 28.8 (44)
25 – 34 41.4 (12) 42.9 (15) 41.2 (63)
35 – 44 20.7 (6) 14.3 (5) 24.8 (38)
45 or older 10.3 (3) 14.3 (5) 5.2 (8)
Smoker
Yes 3.4 (1) 5.1 (2) 2.5 (4)
No 96.6 (28) 94.9 (37) 97.5 (153)
Alcohol consumption:*
Yes 31.0 (9) 28.2 (11) 13.5 (21)
No 69.0 (20) 71.8 (28) 86.5 (134)
Hormonal contraceptive use
Yes 48.3 (14) 67.6 (25) 57.6 (87)
No 51.7 (15) 32.4 (12) 42.4 (64)
Number of sexual partners:
1 – 5 72.4 (21) 94.9 (37) 82.1 (128)
6 – 15 20.7 (6) 5.1 (2) 14.7 (23)
>16 609 (2) 0 3.2 (5)
† Subjects missing
Normal – no abnormal changes.
Dysplasia – abnormal cervical changes including ASCUS, CIN I-III;
ASCUS – atypical squamous cells of undetermined significance
CIN – cervical intraepithelial neoplasia
*X2; P < 0.05Infectious Agents and Cancer 2009, 4(Suppl 1):S11 http://www.infectagentscancer.com/content/4/S1/S11
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not vary significantly by age, number of sexual partners,
age at first sexual encounter, hormonal contraceptive use,
parity or reported history of sexually transmitted diseases.
The median age of the pregnant and non-pregnant
women was 27.5 years and 35 years respectively. Approx-
imately two-thirds of women reported having attained
secondary education and less than 10% were employed in
professional occupations. HPV DNA was detected in
87.7% of the sample; the virus was identified in 90.5% of
pregnant and 83.8% of non-pregnant women.
Cytology results were obtained for 120 pregnant women
and 92 non-pregnant women. Women with cervical dys-
plasia (14/207) had no consistent specific HPV types
present, but many had multiple infections consisting of
high- and low-risk HPV types, of which HPV types 16 and
58 were most common (data not shown). The majority of
women with high-risk infection (93.6%) were diagnosed
with normal cytology (data not shown).
Eighty percent (80.2%) of HPV-positive women had HR-
HPV infections and of these 60.9% had multiple infec-
tions. The percentages of low-risk and single infections
were 61.8% and 34.3% respectively. Figure 1 shows the
most common HR-HPV genotypes found in HPV-positive
women. HPV 45 (21.7%) occurred more frequently than
other HR-types, followed by HPV 58, 16, 35 and 18 at
18.8%, 18.4%, 15.0% and 14.5%, respectively. Other HR-
HPV genotypes were found in frequencies of 1.4% – 7.2%.
There was a wide distribution of genotypes in both groups
of women (36 genotypes detected), although certain gen-
otypes occurred more frequently in pregnant women.
High-risk types 16, 18, 51, 52, 58, 59, and 68 were found
in greater frequencies in pregnant women than non-preg-
nant women. Pregnant women also had the highest fre-
quency of HR-HPV DNA (83.8%) and multiple infections
(66.9%) compared to non-pregnant women (HR-HPV
DNA, 77.1%; multiple infections, 51.8%). Twice as many
pregnant as non-pregnant women had multiple geno-
types present (Table 2).
Examination of the presence of multiple infections by the
above-mentioned variables showed that women who
were pregnant (pregnant, 65.9%) or less than 34 years old
(less than 25 years, 34.2%; 25 – 34 years, 42.5%; 35–44
years, 17.5%; 45 years or older, 5.8%) or were diagnosed
with bacterial vaginosis (17.1%) were more likely to be
infected by multiple genotypes. The patterns of multiple
infections by all other variables were similar to those with
high-risk HPV-positive infections (data not shown).
Univariate regression analyses were used to examine asso-
ciations of behavioural and reproductive factors with
three outcomes: HPV positivity, the presence of multiple
infections and high-risk HPV infections. Women who
consumed alcohol (OR, 0.39; CI, 0.20–0.77) or who were
20 years or older at first sexual intercourse (OR, 0.37; CI,
0.14–1.00) were at decreased risk of high-risk infections.
The presence of bacterial vaginosis at screening (OR, 3.51;
CI, 1.26 – 9.82), being 25 years or younger (OR, 3.70; CI,
1.04–9.07) and pregnancy (OR, 1.72; CI, 1.00–3.04)
increased the risk of multiple infections. There were no
associations of any behavioural or reproductive variables
with HPV positivity.
In multivariate logistic regression analyses, controlling for
age as a potential confounder, we examined significantly
associated variables with high-risk HPV infections and
multiple infections (Table 3). Two variables were associ-
ated with high-risk HPV infections: women who con-
sumed alcohol showed decreased risk (OR, 0.31; CI,
0.15–0.85) whereas being younger at first sexual encoun-
ter was associated with increased risk (12–15 years: OR,
3.56; CI, 1.41–9.12; 16 – 19 years, OR 3.54, CI, 1.22–
10.23) (data not shown). Regarding multiple infections,
being pregnant lost its significance and only bacterial
vaginosis predicted the presence of several genotypes.
Discussion
This study which used cervical cells, a good medium for
detection of HPV DNA [10 ] and the Gravitt et al. detec-
tion method [8], the most sensitive method to date, is
unique in its evaluation of high-risk and multiple HPV
infections in cancer-free Jamaican women. This investiga-
Frequencies of the most common high-risk HPV genotypes in  pregnant and non-pregnant women Figure 1
Frequencies of the most common high-risk HPV genotypes in 
pregnant and non-pregnant women.Infectious Agents and Cancer 2009, 4(Suppl 1):S11 http://www.infectagentscancer.com/content/4/S1/S11
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tion revealed high rates of infections, high levels of multi-
ple infections that included both high- and low-risk
genotypes and a pattern of infection dissimilar to those
described in predominantly European populations.
The most important finding was that unlike the genotype
distribution patterns seen in North America, Europe and
some parts of Asia [11,12] HPV types 16 and 18 were not
the most common high-risk genotypes. In our popula-
tion, HPV types 45 and 58 accounted for 40.5% of the
genotypes. Other groups, e.g. Trinidad and Tobago, Cuba
and parts of Africa [13-18], have also reported different
distributions of genotypes indicating that types 16 and 18
were not predominant in these populations. The recently
developed prophylactic vaccines may therefore not be effi-
cacious in our and similar populations.
Despite the predominance of genotypes other than types
45 and 58 in our population, it is not known whether
these genotypes are important for the development of
cancer. Several authors have suggested that HPV types 51,
52, 56 and 58 may act with HPV 16 in the development of
dysplasia [19-21]. Multiple infections with HPV -16 and -
58 were detected in 50% (7/14) of women with cervical
dysplasia and earlier reports demonstrated the presence of
types 16 and 45 in Colposcopy patients in Jamaica [6].
Further investigations are needed to determine the types
that persist and are responsible for dysplasia and its
sequelae in our population.
The majority of the women (93.2%) including those with
high-risk infections had normal cytology. It has been sug-
gested that cytological abnormalities may resolve before
clearance of high-risk genotypes [22], and this could
explain why in this study the majority of women positive
for high-risk HPV genotypes had no evidence of dysplasia.
Our findings were consistent with the International
Agency for Research on Cancer (IARC) reports that the
most common HPV types in women without cervical
abnormalities were HPV-16, -42, -58, -31, -18, -56, -81, -
35, -33, -45 and -52 [23]. The fact that women with nor-
mal Pap smears may be positive for high-risk HPV geno-
types, suggests that in addition to Pap smears, HPV testing
should be considered.
Various studies have reported prevalence ranging from
14% – 90% [12]. Our rates of infection (87.7%) are simi-
lar to those reported in USA inner city adolescents (90%)
[24] and in HIV-positive Brazilian [25] and Zambian [18]
women (only 2 women were diagnosed HIV-positive in
this study group), but are higher than those reported from
several West African countries (Gabon, 46%; Tanzania,
34% and Gambia, 13%) [15-17] as well as other countries
in the Caribbean (Tobago, 35.4% and Cuba 21.7%)
[13,14]. These findings would argue against a role for
genetic predisposition since these groups share some
common ancestry. Differences in prevalence between this
study and an earlier investigation in Jamaica (1995)
which showed a 28.7% HPV infection prevalence among
women attending a Sexually Transmitted Disease Clinic
[26] may be explained in part by differences in methodol-
ogies.
In our sample younger women were more likely to be pos-
itive with high risk infections or to have multiple infec-
Table 3: Odds ratios (Confidence Interval) for associations with 
high-risk HPV infectionsa and multiple infectionsb in Jamaican 
women.
Odds ratios (CI)
High-risk HPV infections:
Alcohol intake
No 1.0 (reference)
Yes 0.31 (0.15–0.85)
Age at first sexual encounter
20 years or older 1.0 (reference)
16 – 19 3.56 (1.41–9.12)
12 – 15 3.54 (1.22–10.23)
Multiple infections:
Pregnancy status
Non-pregnant 1.0 (reference)
Pregnant 1.67 (0.92, 3.03)
Bacterial vaginosis
No 1.0 (reference)
Yes 2.76 (1.01, 8.02)
a Adjusted for age of participant, age at first sexual intercourse, 
smoking (yes/no), alcohol use (yes/no), bacterial vaginosis (yes/no), 
and pregnancy status (non-pregnant/pregnant).
b Adjusted for age.
Table 2: Number of HPV genotypes present in multiple infections in pregnant and non-pregnant HPV-positive women
HPV-positive women
Non-pregnant women
(n = 43)
Pregnant women (n = 83)
Number of genotypes: n (%)
Two genotypes 16 (37.2) 29 (35.0)
Three genotypes 10 (23.3) 20 (24.1)
>3 genotypes 17 (39.5) 34 (40.9)Infectious Agents and Cancer 2009, 4(Suppl 1):S11 http://www.infectagentscancer.com/content/4/S1/S11
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tions. However, age, was not a significant predictor of any
of the outcome variables. This is in contrast to studies that
show that younger women when compared to their older
counterparts were at greater risk for HPV infection and
that this may be due to older women having acquired
greater immunity to HPV infection [27,28].
Multiple infections were detected in 60.9% of HPV-posi-
tive women. It has been suggested that (i) women with
multiple HPV genotypes may be more prone to persistent
HPV infections, and (ii) there is interaction between gen-
otypes resulting in the development of dysplasia and can-
cer [27,29]. Although in this group of women no specific
patterns of co-infection were observed, women with cervi-
cal dysplasia had multiple infections consisting of high-
risk and low-risk HPV genotypes. The high frequency of
HPV infection, as well as the presence of multiple infec-
tions, is likely to contribute to the high incidence of inva-
sive cervical cancer in Jamaica.
Although we found no relationship with HPV infection
and other STIs (data not shown), a significant association
was observed between the presence of bacterial vaginosis
and multiple infections. Watts et al reported similar find-
ings and suggested that changes in the vaginal flora may
compromise cervical mucosa making it more vulnerable
to HPV infections [30].
More pregnant, than non-pregnant women, in our popu-
lation were found to acquire multiple infections. It is pos-
sible that pregnant women are at heightened
susceptibility to infections as a result of the immunosup-
pression that occurs during pregnancy [31]. Pregnant
women also, may be less likely to use condoms thus
increasing their exposure to infections. In our study how-
ever, whereas pregnancy was associated with multiple
infections in univariate analyses, with adjustment for bac-
terial vaginosis, pregnancy was no longer a predictor.
Other studies have reported that prevalence of HPV infec-
tion among pregnant women increased with gestational
age from 8.0% in the first trimester to 16.7% in the second
and 23.1% in the third trimester [32,33] and that more
than 2 vaginal deliveries were associated with a 3.9 fold
increase in the development of cervical dysplasia [34].
Bazuaye et al. observed that in a population of Jamaican
Colposcopy patients, parity was significantly associated
with the development of cervical dysplasia [35].
Conclusion
Our results indicate that genotype distribution in Jamaica
differs from that found in Europe, North America and
some parts of Asia. This has implications for the use of the
recently developed vaccines, in Jamaica and similar popu-
lations. HPV genotyping as well as Pap smears should be
considered for additional testing.
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